Skip to main content

Delaney Mark E's Form 4 filing

Quest Diagnostics Inc (DGX) · filed Nov 20, 2025

Accession no.
0001955265-25-000004
Filed
Nov 20, 2025
Trade date
Nov 18, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.49M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Delaney Mark ECIK 0001955265Officer (SVP & Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 18, 2025Common StockMOption exerciseAcquired+7,846$144.47+$1,133,511.6215,376Direct
Nov 18, 2025Common StockMOption exerciseAcquired+100$143.33+$14,33315,476Direct
Nov 18, 2025Common StockSSaleDisposed−7,946$187.35−$1,488,683.17,530Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 18, 2025Common StockMOption exerciseDisposed−7,846$144.47−$1,133,511.620Direct
Nov 18, 2025Common StockMOption exerciseDisposed−100$143.33−$14,3337,484Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)